Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
ICON PUBLIC LIMITED COMPANY |
Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 267.58 USD | -0.68% | -1.29% | +37.75% | |
| Nov. 14 | Transcript : ICON Public Limited Company Presents at 14th Annual Jefferies London Healthcare Conference 2023, Nov-14-2023 02:00 PM | CI |
| Nov. 07 | All good things must come to an end |  |
Chart calendar ICON Public Limited Company
ebcd9b57206893a8.jxDySobG6k9wg4C9-b9_h67hCfzqxAi_h-G_qQmBeOo.6GK3ObWj3A0V8fKOl-sp8M-lR6iBlT3y6ZOKyEDtNKLLXadnzKW9fDHb6w~c9ff6e9ad9b186d06a1cf3d595ec907a
Upcoming events on ICON Public Limited Company
Past events on ICON Public Limited Company
| 2023-11-20 | OCT DACH Conference |
| 2023-11-14 | EBF Conference |
| 2023-11-14 09:00 am | Jefferies London Healthcare Conference |
| 2023-11-12 | European Site Solutions Summit |
| 2023-11-11 | ISPOR EU Conference |
| 2023-10-29 | World Orphan Drug EU Congres |
| 2023-10-26 08:00 am | Q3 2023 Earnings Call |
| 2023-10-25 04:15 pm | Q3 2023 Earnings Release |
| 2023-10-24 | Medical Innovation Forum |
| 2023-10-23 | OCT Nordics Conference |
| 2023-10-21 | AAPS PharmSci Conference |
| 2023-10-15 | WVC EU Conference |
| 2023-10-05 | Global Site Solutions Summit |
| 2023-09-25 | OCT Southern California Conference - Panel |
| 2023-09-20 | Dpharm US Conference |
| 2023-09-20 08:00 am | Mobile Tech in Clinical Trials Conference |
| 2023-09-15 10:30 am | Cardiovascular Tech Summit |
| 2023-09-13 12:20 pm | Operationalize Decentralized Clinical Trials Summit |
| 2023-09-13 11:40 am | Operationalize Decentralized Clinical Trials Summit |
| 2023-09-13 10:15 am | Baird Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2 596 2 592 0.13% | 2 806 2 814 -0.29% | 2 797 2 788 0.32% | 5 481 5 494 -0.24% | 7 741 7 744 -0.04% | 8 147 |
|
EBITDA Million USD | Released Forecast Spread | 452 454 -0.39% | 495 494 0.18% | 476 471 1.01% | 970 964 0.67% | 1 479 1 463 1.1% | 1 684 |
|
EBIT Million USD | Released Forecast Spread | 386 384 0.49% | 433 433 0.15% | 410 403 1.69% | 655 863 -24.1% | 1 373 1 367 0.43% | 1 562 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 365 364 0.29% | 427 426 0.2% | 381 378 0.84% | 197 399 -50.72% | 568 627 -9.5% | 642 |
|
Net income Million USD | Released Forecast Spread | 323 322 0.29% | 374 374 -0.07% | 332 330 0.82% | 153 291 -47.4% | 505 525 -3.68% | 554 |
|
EPS USD | Released Forecast Spread | 5,89 5,90 -0.13% | 6,79 6,89 -1.42% | 6,15 6,17 -0.38% | 2,25 3,19 -29.47% | 6,13 6,78 -9.58% | 6,77 |
| Announcement Date | 20/02/19 | 19/02/20 | 24/02/21 | 22/02/22 | 22/02/23 | - |
Quarterly results
| Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 866 1 835 1.69% | 1 885 1 894 -0.47% | 1 902 1 887 0.8% | 1 935 1 928 0.38% | 1 942 1 934 0.42% | 1 962 1 965 -0.14% | 1 979 1 982 -0.15% | 2 020 2 017 0.15% | 2 055 2 055 0.02% | 2 093 | 2 107 | 2 152 | 2 201 | 2 240 |
|
EBITDA Million USD | Released Forecast Spread | 325 317 2.55% | 333 335 -0.75% | 341 332 2.61% | 354 349 1.54% | 380 371 2.29% | 405 396 2.36% | 399 398 0.39% | 414 412 0.62% | 433 425 1.77% | 440 | 436 | 449 | 464 | 474 |
|
EBIT Million USD | Released Forecast Spread | 214 255 -16.25% | 193 297 -35.14% | 314 306 2.47% | 329 314 4.55% | 353 342 3.09% | 378 370 2.13% | 254 365 -30.45% | 209 383 -45.3% | 401 396 1.4% | 408 | 403 | 418 | 430 | 439 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -97,1 244 -139.77% | 91,8 190 -51.67% | 126 196 -35.71% | 131 184 -28.72% | 182 199 -8.32% | 129 214 -39.78% | 131 160 -17.93% | 125 168 -25.35% | 182 187 -2.59% | 214 | 211 | 228 | 251 | 269 |
|
Net income Million USD | Released Forecast Spread | -94,3 127 -174.42% | 76,5 139 -44.87% | 112 165 -32.04% | 116 139 -16.98% | 160 155 3.43% | 117 164 -28.49% | 117 122 -4.23% | 116 162 -28.69% | 164 164 -0.32% | 172 | 176 | 194 | 212 | 225 |
|
EPS USD | Released Forecast Spread | -1,17 1,38 -184.99% | 0,92 1,62 -43.21% | 1,36 1,76 -22.87% | 1,41 1,64 -13.95% | 1,94 1,82 6.59% | 1,42 2,15 -33.84% | 1,41 1,48 -4.57% | 1,40 1,67 -16.17% | 1,97 1,98 -0.32% | 2,11 | 2,10 | 2,34 | 2,55 | 2,69 |
| Announcement Date | 11/03/21 | 02/22/22 | 04/27/22 | 07/27/22 | 11/02/22 | 02/22/23 | 04/26/23 | 07/26/23 | 10/25/23 | - | - | - | - | - |
| 2024-01-22 | Q3 2024 Earnings Release (Projected) |
| 2024-01-23 | Q4 2023 Earnings Release (Projected) |
| 2024-01-31 | Q3 2023 Earnings Release (Projected) |
| 2024-02-02 12:45 am | Q4 2023 Earnings Release |
| 2024-02-05 | Q1 2024 Earnings Release (Projected) |
| 2024-02-05 | Q2 2024 Earnings Release (Projected) |
| 2024-02-05 | Q4 2023 Earnings Release (Projected) |
| 2024-02-06 | Q1 2024 Earnings Release (Projected) |
| 2024-02-07 | Q4 2023 Earnings Release (Projected) |
| 2024-02-07 | Q4 2023 Earnings Release (Projected) |
Past sector events for ICON Public Limited Company
| 2023-11-27 | Q3 2023 Earnings Release |
| 2023-11-15 | Q3 2023 Earnings Release (Projected) |
| 2023-11-15 04:01 pm | Q3 2023 Earnings Release |
| 2023-11-14 04:05 pm | Q3 2023 Earnings Release |
| 2023-11-14 04:01 pm | Q3 2023 Earnings Release |
| 2023-11-14 07:00 am | Q3 2023 Earnings Release |
| 2023-11-14 06:30 am | Q3 2023 Earnings Release |
| 2023-11-13 | Q3 2023 Earnings Release (Projected) |
| 2023-11-13 | Q3 2023 Earnings Release |
| 2023-11-13 08:15 pm | Q3 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock ICON Public Limited Company - Nasdaq
- Calendar ICON Public Limited Company